1. Home
  2. GHG vs VTVT Comparison

GHG vs VTVT Comparison

Compare GHG & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

N/A

Current Price

$1.06

Market Cap

101.9M

ML Signal

N/A

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

N/A

Current Price

$21.00

Market Cap

104.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GHG
VTVT
Founded
2004
2015
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.9M
104.9M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
GHG
VTVT
Price
$1.06
$21.00
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $56.00
AVG Volume (30 Days)
★ 44.9K
14.2K
Earning Date
12-22-2026
11-05-2026
Dividend Yield
★ 5.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$56.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.76
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.91
$20.56
52 Week High
$1.99
$44.00

Technical Indicators

Market Signals
Indicator
GHG
VTVT
Relative Strength Index (RSI) 58.20 22.64
Support Level $0.92 N/A
Resistance Level $1.13 $34.65
Average True Range (ATR) 0.07 1.40
MACD 0.01 -0.34
Stochastic Oscillator 78.94 4.59

Price Performance

Historical Comparison
GHG
VTVT

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Share on Social Networks: